These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1071667)

  • 1. Increased plasma noradrenaline concentrations in essential hypertension and their decrease after long-term treatment with a beta-receptor-blocking agent (prindolol).
    Brecht HM; Banthien F; Ernst W; Schoeppe W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():485S-488S. PubMed ID: 1071667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.
    Brecht HM; Banthien F; Schoeppe W
    Klin Wochenschr; 1976 Nov; 54(22):1095-105. PubMed ID: 1003867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a beta-receptor-blocking agent (prindolol) in essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():551s-554s. PubMed ID: 1071679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Adv Clin Pharmacol; 1976; 11():66-9. PubMed ID: 1032572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
    Schoeppe W; Brecht HM
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adrenaline and noradrenaline in essential hypertension and after long-term treatment with beta-adrenoreceptor-blocking agents.
    Franco-Morselli R; Baudouin-Legros M; Meyer P
    Clin Sci Mol Med Suppl; 1978 Dec; 4():97s-100s. PubMed ID: 32010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma catecholamines following exercise in hypertensives treated with pindolol: comparison with placebo and metoprolol.
    Vandongen R; Margetts B; Deklerk N; Beilin LJ; Rogers P
    Br J Clin Pharmacol; 1986 Jun; 21(6):627-32. PubMed ID: 3741714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential changes in plasma noradrenaline during bicycle exercise.
    Watson RD; Hamilton CA; Jones DH; Reid JL; Stallard TJ; Littler WA
    Clin Sci (Lond); 1980 Jan; 58(1):37-43. PubMed ID: 7353352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma noradrenaline concentration and alpha-adrenoceptor-mediated vasoconstriction in normotensive and hypertensive man.
    Kiowski W; Bühler FR; van Brummelen P; Amann FW
    Clin Sci (Lond); 1981 May; 60(5):483-9. PubMed ID: 7249534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma catecholamine responses to change of posture in alcoholics during withdrawal and after continued abstinence from alcohol.
    Eisenhofer G; Whiteside EA; Johnson RH
    Clin Sci (Lond); 1985 Jan; 68(1):71-8. PubMed ID: 3964731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of plasma noradrenaline to blood pressure, age, sex and sodium balance in patients with stable essential hypertension and in normotensive subjects.
    Brecht HM; Schoeppe W
    Clin Sci Mol Med Suppl; 1978 Dec; 4():81s-83s. PubMed ID: 282104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels.
    Anavekar SN; Louis WJ; Morgan TO; Doyle AE; Johnston CI
    Clin Exp Pharmacol Physiol; 1975; 2(3):203-12. PubMed ID: 1149326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension.
    Distler A; Keim HJ; Cordes U; Philipp T; Wolff HP
    Am J Med; 1978 Mar; 64(3):446-51. PubMed ID: 25017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor-blocking drugs.
    Morgan T; Carney S; Roberts R
    Clin Sci Mol Med Suppl; 1975 Jun; 2():81s-83s. PubMed ID: 802647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the beta-receptor-blocker prindolol on renal hypertension (author's transl)].
    Undeutsch K; Sieberth HG; Meurer KA
    Klin Wochenschr; 1976 Nov; 54(22):1077-84. PubMed ID: 1003866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of prindolol on the blood-pressure profile of hypertensives (with special consideration of response to exercise and plasma-renin activity) (author's transl)].
    Dufey K; Krönig B; Fries G; Gunkel R; Walter U; Wolff HP
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1726-30. PubMed ID: 1157670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma noradrenaline concentrations and haemodynamics in the early stage of essential hypertension.
    Miura Y; Kobayashi K; Sakuma H; Tomioka H; Adachi M; Yoshinaga K
    Clin Sci Mol Med Suppl; 1978 Dec; 4():69s-71s. PubMed ID: 282101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of noradrenaline in the pathogenesis of essential hypertension. Preliminary report].
    Weidmann P; Keusch G; Flammer J; Ziegler WH; Reubi FC
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1974-6. PubMed ID: 749196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.